Is Avient Corp. overvalued or undervalued?

As of 24 October 2025, the valuation grade for Avient Corp. has moved from expensive to very expensive, indicating a significant deterioration in its valuation standing. The company is overvalued based on its current metrics, with a P/E ratio of 126, a Price to Book Value of 1.97, and an EV to EBITDA of 14.53. In comparison, peers such as Eastman Chemical Co. have a much lower P/E of 15.68 and EV to EBITDA of 10.37, highlighting the disparity in valuation.
Additionally, Avient Corp.'s recent stock performance has been underwhelming, with a year-to-date return of -20.14% compared to the S&P 500's positive return of 15.47%, and a one-year return of -32.11% against the S&P 500's 16.90%. This further reinforces the notion that the stock is not only overvalued but also struggling in the market.